No Detail Found!

Relationships among Immune Score, TCF21 Methylation, Risk-factor Level, and Prognosis in Prostate Cancer

Author(s)
Wei Zhang Department of Urology, Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou,China
Zhiyang Huang Department of Urology, Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou,China
Jun Xin Department of Urology, Quanzhou First Hospital Affiliated to Fujian Medical University,Quanzhou,China
Abstract
Objective: To determine whether the immune score and methylation levels of transcription factor 21 (TCF21) could be used as independent diagnostic indicators and prognostic predictors in prostate cancer (PCA). Study Design: A descriptive study. Place and Duration of Study:Department of Urology, Quanzhou First Hospital A liated to Fujian Medical University, from November 2017 to December 2019. Methodology: Cases of PCA were for numbers of CD3+ and CD8+ T lymphocytes in the nests and stromal regions of PCA tissues. The percentage of CD8+ T lymphocytes in the peripheral blood was measured. TCF21 methylation was detected. The patient samples were classi ed according to risk-factor level, the immune score aTnCdF21 methylation levels were subsequently determined. The time of e ective hormone therapy was calculated. The relationships among immune scoTrCeF,21 methylation level, PCA risk-factor level and the time of e ective hormone therapy were determined. Results: There was no signi cant di erence of the proportions of CD8+ T cells in the peripheral blood between di erent T stage groups and di erent Gleason scores groups. The authors found negative linear relationships between immune score and risk-factor level, PSA level and Gleason score (p 0.05). The immune score correlated with the time of e ective hormone therapy (p =0.002). There was signi cant correlation between TCF21 methylation and PSA, Gleason score, risk-factor level and immune score (p 0.05). Conclusion: The immune score and TCF21 methylation could be used as independent indicators for the diagnosis and prognosis of PCA.
Publication Details
Page(s) 319-323
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 32, Issue: 3, Year: 2022

Request the full text from PASTIC

Keywords
DNA methylation, Prostatic neoplasms, Immunity cellular
0

Citations

0

Downloads

46

Views